Percutaneous Valve Technologies
This article was originally published in The Gray Sheet
Executive Summary
Privately held PVT raises $5.5 mil. from a Series A financing led by Oxford Bioscience Partners and Medica Venture Partners. Proceeds will go towards developing a minimally invasive device for treating aortic stenosis, which combines balloon-expandable stent technology with bioprosthetic valves, Englewood, New Jersey-based PVT explains